News - FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Psychiatry Other

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Psychiatry Other

	FDA Approves Aripiprazole to Treat Irritability Associated With Autistic Disorder - (DGNews)
	FDA Approves Ziprasidone for Adjunctive Maintenance Treatment of Bipolar Disorder - (DGNews)
	Aripiprazole Generally Safe, Tolerable for Children With Autism-Related Irritability: Presented at AACAP - (DGDispatch)
	Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA - (DGDispatch)
	Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents - (JAMA)

News archive

Recent webcasts/CME - Psychiatry Other

Applying Evidence to Practice in Major Depressive Disorder: An Interactive Panel Discussion
Practical Considerations for Front-Line Therapy in MDD
Improving Outcomes and Overcoming Barriers in Treatment-Refractory MDD: Practical Strategies and Insights
Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions
Understanding the Potential Etiologies of Fibromyalgia

Webcasts/CME archive

Recent cases - Psychiatry Other

	Female Sexual Dysfunction as a Comorbid Illness
	11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
	Comorbidity of Asperger's Syndrome and Bipolar Disorder
	Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
	Treating Bipolar Disorder in Patients with Renal Failure Having Haemodialysis: Two Case Reports

Cases archive

my personal edition > psychiatry other > news

E-Mail this DGNews to a colleague

DGNews

FDA Approves Abilify (Aripiprazole) for Treatment of Acute Bipolar Mania, Including Manic and Mixed Episodes

NEW YORK, NY -- October 4, 2004 -- The FDA has approved Abilify® (aripiprazole), for the treatment of acute bipolar mania, including manic and mixed episodes in patients with bipolar disorder.

More than 2 million Americans suffer from bipolar I disorder, a condition that causes extreme mood changes alternating between episodes of mania (highs), when the person's mood is elated and judgment impaired, and depression (lows), when the person may feel hopeless and believe they cannot be helped.

For bipolar I disorder, medicine plays a key role in helping manage symptoms. However, taking medicine as prescribed can be difficult. Because patients vary in their response to medication, it is important to have several treatment options available to help healthcare providers find an optimal treatment plan for each patient.

SOURCE: Bristol-Myers Squibb

E-Mail this DGNews to a colleague To print, use this version